Assaf Harofe Medical Center,
Zrifin, Israel
NCT Number: NCT01327352
The study will be a non-randomized, open label, single dose, placebo control, single center, and single arm study in healthy subjects. The study will include one administration of placebo and four single administrations of Oshadi D in two different dose levels, administered in two feeding regimen for the evaluation of the influence of food on Oshadi D absorption.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Zrifin, Israel
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
oral administration
Time frame: 24 hours
Time frame: 24 hours
Oshadi Drug Administration
Industry
A Single Center, Non-randomized, Placebo Controlled Study for the Evaluation of the Influence of Food Regimen on Oshadi D Absorption
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02822989
Autoimmune Diseases, Connective Tissue Diseases
Manhasset, New York, United States
View Trial DetailsNCT02732470
Autoimmune Diseases, Connective Tissue Diseases
Limoges, France
View Trial DetailsNCT05961267
Ankylosis, Arthritis
Bordeaux, France
View Trial DetailsNCT03527472
Autoimmune Diseases, Cognition Disorders
Cleveland, Ohio, United States
View Trial Details